Denise Isabel Guevara Cando

Denise Isabel Guevara Cando

Auto-generated profile, based on publicly available information

Denise Isabel Guevara Cando

Universidad Nacional de Chimborazo

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2024 in Ibero-American Journal of Health Science Research
Verified
Journal Article
Open access
PDF file
DADiana Lorena Pedrosa Astudillo
Diana Lorena Pedrosa Astudillo
ITInés Patricia Jara Tapia
Inés Patricia Jara Tapia
LGLizbeth Carolina López García
Lizbeth Carolina López García
TSTiffany Ivanna Guerrero Solorzano
Tiffany Ivanna Guerrero Solorzano
AHAlberto Fabián Corral Chang Huang
Alberto Fabián Corral Chang Huang
DCDenise Isabel Guevara Cando
Denise Isabel Guevara Cando
Hypothyroidism, which is developed in 4-10 % of the population, and subclinical hypothyroidism found in more than 10 % of people which are highly associated with cardiovascular pathophysiology at some level. Hypothyroidism, which is the most frequent endocrine disorder with a lack of enough thyroid hormones, presents a wide range of cardiovascular complications, including coronary artery disease, heart failure, and dyslipidemia. Thyroid hormone replacement therapy, particularly levothyroxine (LT4), continues to be the central management of hypothyroidism, which aims to restore euthyroidism and other cardiac comorbidities as well as relieving symptoms. Nonetheless, the complex interworking of thyroid function and cardiovascular health requires a detailed clarification of the processes associated with disease development and drug therapy. Hypothyroidism triggers a chain of cardiovascular alterations such as aberrant lipid metabolism, endothelial dysfunction, and lessened cardiac contractility primarily by lowering the thyroid hormone level. Besides, these modifications eventually lead to raised rates of atherosclerosis, myocardial infarction, and heart failure. LT4 replacement therapy achieves normalization of hyperthyroidism with the replacement of thyroid hormone deficiency, which restores the cardiovascular system to normal by doing so. LT4 modulates lipid metabolism, improves endothelial function, and stimulates myocardial contractility via several different mechanisms. LT4 therapy acts on systemic inflammation and oxidation to accentuate the protective effects of the cardiovascular system. Apart from this, there is an increasing awareness about the use of new thyroid hormone formulations, like LH4, in the therapy of hypothyroidism. LH4, the thyromimetic compound, demonstrated a similar binding affinity at the thyroid hormone receptor as T3 (triiodothyronine) but with better tissue selectivity and more metabolic stability. Clinical trials have proven the potency of LH4 in lowering symptoms of hypothyroidism, for example, fatigue, weight gain which are leading cause of cardiovascular disorders. LH4 administration has been safe for up to six months, and only mild adverse effects have been reported when it is used more than a year.

2 July 2025 in Esprint Investigación
Verified
Journal Article
Open access
PDF file
DCDenise Isabel Guevara Cando
Denise Isabel Guevara Cando
LRLuisa Paulina Chafla Romero
Luisa Paulina Chafla Romero
Durante el proceso de gestión de atención sanitaria en los sistemas de salud, el agendamiento de citas médicas es importante debido a que influye de forma directa en el servicio y en la calidad de atención al paciente. La presente investigación tuvo como objetivo analizar las diferentes modalidades de agendamiento de citas médicas y su impacto en la calidad de la atención al usuario. Se realizó una revisión sistemática de la literatura basada en la guía PRISMA. Se incluyeron estudios en español e inglés, publicados entre 2015 y 2025, que evaluaron indicadores como tiempos de espera, satisfacción del paciente, eficiencia y reducción de inasistencias. La búsqueda se efectuó en PubMed, Dialnet y Google Scholar, utilizando descriptores Medical Subject Headings (MeSH) y operadores booleanos, se trabajó con 25 artículos. Se analizaron dimensiones como modalidad de agendamiento, eficiencia, satisfacción del usuario y calidad de atención, sistematizando los datos de forma cualitativa y cuantitativa. Los hallazgos más relevantes demostraron que los sistemas en línea reducen los tiempos de espera y aumentan la satisfacción del usuario, debido a que disminuyen las inasistencias y mejoran la eficiencia institucional. Sin embargo, se observó que si la tecnología médica no consta de un soporte adecuado puede generar fallos en el sistema. Se concluye que los sistemas híbridos, junto con un fortalecimiento organizacional y humano, son claves para una implementación exitosa de los sistemas de agendamiento.